142 assets in Head And Neck Cancer

Therapeutic assets addressing Head And Neck Cancer, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Brodalumab Head And Neck Cancer	Brian Henick, MD	P1	C (39)
ca9hu-1 Head And Neck Cancer	Mabpro, a.s.	P1	C (39)
Cabozantinib Head And Neck Cancer	Exelixis	P1	C (39)
Crpa1A2 Head And Neck Cancer	Corregene Biotechnology Co., Ltd	P1	C (39)
Definity Head And Neck Cancer	Thomas Jefferson University	P1	C (39)
dk210 Head And Neck Cancer	DEKA Biosciences	P1	C (39)
Epi-326 Head And Neck Cancer	EpiBiologics	P1	C (39)
ft536 Head And Neck Cancer	Fate Therapeutics	P1	C (39)
Futibatinib Head And Neck Cancer	Taiho Pharmaceutical Co., Ltd.	P1	C (39)
Immunoglobulin G1, Anti-(Human Vascular Endothelial Growth Factor Receptor Type Vegfr-2 Extracellular Domain) (Human Monoclonal Imc-1121B .Gamma.-Chain), Disulphide With Human Monoclonal Imc-1121B .Kappa.-Chain, Dimer Head And Neck Cancer	Taiho Pharmaceutical Co., Ltd.	P1	C (39)
Immunoglobulin G1-Kappa, Anti-[Homo Sapiens Tigit (T-Cell Immunoreceptor With Ig Domain And Itim, V-Set Ig Member 9, Vsig9, V-Set And Transmembrane Member 3, Vstm3)], Humanized Monoclonal Antibody; Gamma1 Heavy Chain Humanized (1-448) [Vh (Homo Sapiens Ighv3-4801 (90.8%) -(Ighd) -Ighj401 (92.3%)) Cdr-Imgt [8.8.12] (26-33.51-58.97-108) (1-119) -Homo Sapiens Ighg101, G1M17,1, G1V14 Ch2 A1.3, A1.2 (Ch1 K120 (216) (120-217), Hinge 1-15 (218-232), Ch2 L1.3>A (236), L1.2>A (237) (233-342), Ch3 D12 (358), L14 (360) (343-447), Chs K>Del (448)) (120-448)], (222-214')-Disulfide With Kappa Light Chain Humanized (1'-214') [V-Kappa (Homo Sapiens Igkv1-1601 (89.5%) -Igkj401 (100%)) Cdr-Imgt [6.3.9] (27-32.50-52.89-97) (1'-107') -Homo Sapiens Igkc01 (100%) Km3 A45.1 (153), V101 (191) (108'-214')]; Dimer (228-228'':231-231'')-Bisdisulfide, Produced In A Chinese Hamster Ovary (Cho)-K1 Cell Line, Glycoform Alfa Head And Neck Cancer	Taiho Pharmaceutical Co., Ltd.	P1	C (39)
inn805 Head And Neck Cancer	FindCure Biosciences (ZhongShan) Co., Ltd.	Early P1	C (39)
Mem-288 Intratumoral Head And Neck Cancer	Memgen, Inc.	P1	C (39)
Ncp-Cd47 Sirna Intratumorally Head And Neck Cancer	West China Hospital	P1	C (39)
Oct-598 Head And Neck Cancer	Oscotec Inc.	P1	C (39)
pf-07263689 Head And Neck Cancer	Pfizer	P1	C (39)
pf-07921585 Head And Neck Cancer	Pfizer	P1	C (39)
pf-08046876 Head And Neck Cancer	Pfizer	P1	C (39)
Pimitespib Head And Neck Cancer	Taiho Pharmaceutical Co., Ltd.	P1	C (39)
syh2051 Head And Neck Cancer	CSPC ZhongQi Pharmaceutical Technology Co., Ltd.	P1	C (39)
Tas-102 Head And Neck Cancer	Taiho Pharmaceutical Co., Ltd.	P1	C (39)
Tas-115 Head And Neck Cancer	Taiho Pharmaceutical Co., Ltd.	P1	C (39)
Tsc-200-A0201 Head And Neck Cancer	TScan Therapeutics, Inc.	P1	C (39)
Tsc-201-B0702 Head And Neck Cancer	TScan Therapeutics, Inc.	P1	C (39)
Tsc-202-A0201 Head And Neck Cancer	TScan Therapeutics, Inc.	P1	C (39)
Tsc-203-A0201 Head And Neck Cancer	TScan Therapeutics, Inc.	P1	C (39)
Tsc-204-A0101 Head And Neck Cancer	TScan Therapeutics, Inc.	P1	C (39)
Tsc-204-A0201 Head And Neck Cancer	TScan Therapeutics, Inc.	P1	C (39)
Tsc-204-C0702 Head And Neck Cancer	TScan Therapeutics, Inc.	P1	C (39)
Vrp-Encapsulated Sarna Encoding Il-12 Head And Neck Cancer	VLP Therapeutics	P1	C (39)
Wm-A1-3389 Head And Neck Cancer	Wellmarker Bio	P1	C (39)
Zi-Ma4-1 Head And Neck Cancer	Zelluna Immunotherapy AS	P1	C (39)
Zimberelimab Head And Neck Cancer	Taiho Pharmaceutical Co., Ltd.	P1	C (39)
Anti-Pd-L1 Monoclonal Antibody Ck-301 Head And Neck Cancer	Checkpoint Therapeutics, Inc.	P1	C (38)
Avelumab Head And Neck Cancer	Fate Therapeutics	P1	C (38)
[Ga-68]Mtp220 Head And Neck Cancer	Qiubai Li	Early P1	C (36)
R130 Head And Neck Cancer	Shanghai Yunying Medical Technology	Early P1	C (36)
Recombinant L-Ifn Adenovirus Head And Neck Cancer	Shanghai Fengxian District Central Hospital	Early P1	C (36)
Panthenol Head And Neck Cancer	Angelos Kassianos	N/A	D (30)
Sasanlimab Head And Neck Cancer	Pfizer	P1	D (28)

Showing 101 to 142 of 142 assets

PreviousPage 3 of 3Next